In an investigation of 162 tumor and normal tissues of breast, lack of AKAP3 expression was observed to be significantly associated with triple-negative breast cancer, breast tumor size, tumor stage, and 5-year disease-free survival (93). Here, AKAP3 is linked to triple-negative breast carcinoma.